HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pharmacological treatment of disabling tremor.

Abstract
Tremor is often a disabling primary condition or secondary to another disorder. No universally effective pharmacological agent exists for the treatment of essential tremor, and patients differ greatly in their response to therapies, thus requiring individualised regimens. Deep brain stimulation is the best option for patients with disabling, drug-resistant essential tremor. Resting tremor in Parkinson's disease is usually not the primary disabling feature, and in most cases, levodopa/carbidopa is satisfactory for many years. Young Parkinson's patients with dominant, disabling tremor benefit from anticholinergics in addition to dopaminergic therapies. However, older Parkinson's patients with more disabling tremor may suffer from dose-dependent side effects, and deep brain stimulation should be considered. This article outlines the available pharmacological agents and treatment considerations for various disabling tremors, including essential tremor and Parkinson's disease.
AuthorsCourtney R Schadt, Ennis I Duffis, P David Charles
JournalExpert opinion on pharmacotherapy (Expert Opin Pharmacother) Vol. 6 Issue 3 Pg. 419-28 (Mar 2005) ISSN: 1744-7666 [Electronic] England
PMID15794733 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Chemical References
  • Primidone
  • Propranolol
  • Botulinum Toxins, Type A
Topics
  • Botulinum Toxins, Type A (therapeutic use)
  • Dystonia (drug therapy)
  • Essential Tremor (drug therapy)
  • Humans
  • Parkinson Disease (drug therapy)
  • Primidone (therapeutic use)
  • Propranolol (therapeutic use)
  • Tremor (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: